Home > Healthcare > Medical Devices > Diagnostic Devices > Intracranial Pressure (ICP) Monitoring Devices Market

Intracranial Pressure (ICP) Monitoring Devices Market Size

  • Report ID: GMI3339
  • Published Date: Feb 2024
  • Report Format: PDF

Intracranial Pressure Monitoring Devices Market Size

Intracranial Pressure (ICP) Monitoring Devices Market size was valued at USD 1.7 billion in 2023 and is estimated to grow at a CAGR of 6.8% between 2024 and 2032. Intracranial pressure (ICP) monitoring devices are medical devices used to measure and monitor the pressure inside the skull and brain. These devices play a crucial role in the management of patients with severe traumatic brain injuries, intracranial hemorrhages, hydrocephalus, or other neurological conditions associated with elevated intracranial pressure.

 

The increasing prevalence of various neurological disorders and traumatic accidents has emerged as a significant public health concern worldwide. For instance, the World Stroke Organization (WSO) states that ischemic stroke poses a significant health concern, with approximately 7.6 million new cases reported each year. This persistent increase, propelled by aging and lifestyle-related factors, emphasizes the urgency for effective treatments like intracranial pressure (ICP) monitoring.
 

Furthermore,growing government initiatives and policies, rising awareness and screening programs for monitoring intracranial pressure, rising healthcare expenditure, and increasing adoption of neurostimulation devices which is set to reach USD 25.5 billion by 2032, among other contributing factors propelling the growth of the market in the forthcoming years.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of intracranial pressure (ICP) monitoring devices reached USD 1.7 billion in 2023 and is set to witness 6.8% CAGR from 2024 to 2032, owing to the increasing prevalence of various neurological disorders and traumatic accidents.

The invasive segment is estimated to account for USD 2.5 billion by 2032, as it allows for direct measurement of intracranial pressure, providing highly accurate and reliable data for clinical decision-making.

North America market held over USD 701.7 million in 2023, due to the growing prevalence of neurological conditions and traumatic brain injuries, coupled with advancements in medical technology.

Brain4Care Inc., CranioSense, LLC, HeadSense Medical Ltd., Integra LifeScience Holdings Corporation, Johnson & Johnson, Luciole Medical AG, Medtronic plc, Natus Medical Inc., RAUMEDIC AG, Sophysa, and Vittamed Corporation.

Intracranial Pressure Monitoring Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 404
  • Countries covered: 22
  • Pages: 260
 Download Free Sample